Posaconazole for chronic refractory coccidioidal meningitis

Clinical Infectious Diseases

Volumn 53, Issue 12, 2011, Pages 1252-1254

  Schein, Rebecca ^a   Homans, James ^a   Larsen, Robert A ^b   Neely, Michael ^a  

^a Maternal Child and Adolescent Center for Infectious Diseases and Virology   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; ANASTOMOSIS; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; DRUG DOSE INCREASE; DRUG MEGADOSE; HUMAN; HYDROCEPHALUS; LABORATORY TEST; MALE; MONOTHERAPY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CHRONIC DISEASE; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; HUMANS; MALE; MENINGITIS, FUNGAL; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 81855192064     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir734     Document Type: Article

References (12)

1. Galgiani J. Coccidioides species. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone Elsevier, 2010; 3333-44.
2. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. Ann Intern Med 1993; 119:28-35. (Pubitemid 23177294)
3. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996; 124:305-10. (Pubitemid 26047456)
4. Cortez KJ, Walsh TJ, Bennett JE. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 2003; 36:1619-22. (Pubitemid 36783349)
5. Proia LA, Tenorio AR. Successful use of voriconazole for treatment of coccidioides meningitis. Antimicrob Agents Chemother 2004; 48:2341. (Pubitemid 38691647)
6. Antony SJ, Jurczyk P, Brumble L. Successful use of combination antifungal therapy in the treatment of coccidioides meningitis. J Natl Med Assoc 2006; 98:940-2. (Pubitemid 43846253)
7. Hussaini T, Rüping MJGT, Farowski F, Vehreschild JJ, Cornely OA. Therapeutic drug monitoring of voriconazole and posaconazole. Pharmacotherapy 2011; 31:214-25.
8. Barchiesi F, Spreghini E, Schimizzi A, et al. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection. Antimicrob Agents Chemother 2004; 48:3312-6. (Pubitemid 39129324)
9. Stevens DA, Rendon A, Gaona-Flores V, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest 2007; 132: 952-8.
10. Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis 2007; 45:562-8. (Pubitemid 47328635)
11. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 2005; 40:1770-6. (Pubitemid 40799946)
12. Perfect JR, Cox GM, Dodge RK, Schell WA. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob Agents Chemother 1996; 40:1910-3. (Pubitemid 26277814)